In-Depth: Mergers and Acquisitions
Lexology In-Depth: Mergers and Acquisitions – Edition 17
Market participants have adapted to the covid-19 pandemic and supply chain issues, which
resulted in robust private equity activity until around mid-2022. From mid-2022, activity
started to slow down in general, but in particular in the venture capital sector and less so
in the growth capital segment, as investors got more cautious given the macro-economic
downturn. This may cause certain auctions scheduled for 2023 to be postponed until there
is better overall visibility. We would also expect distressed M&A to pick up in 2023 as this
time around no government support schemes are planned.

Disclaimer
Dieser Blog stellt lediglich eine allgemeine Information und keine rechtsanwaltliche Beratung dar. Schindler Rechtsanwälte GmbH übernimmt keine Haftung für die Richtigkeit, Vollständigkeit und Aktualität des Blogs. Der Blog kann eine individuelle Rechtsberatung nicht ersetzen.
Deals & Insights
Latest News, Events, and Perspectives
Schindler Attorneys Advised RENOMIA on its Investment in KOBAN SÜDVERS Group
Business & Law Circle 2026
CEO Panel 2026 – Nicht immer auf die Politik warten
Schindler Attorneys Advised GRO Capital on its Investment in Toolsense
Schindler Attorneys Advises Armira Growth on Strategic Investments in Aviloo and nyra health
Schindler Attorneys Advised BC Partners-Backed IGS GeboJagema on Acquisition of ACH solution
Schindler Attorneys Advised Deutsche Beteiligungs AG (DBAG) on Investment in Great Lengths
New guidance of the FDI authority regarding approval requirements in Austria
Schindler Attorneys advised Waters Corporation on Combination with BD’s Biosciences & Diagnostic Solutions business
Schindler Attorneys advised Waters Corporation on transformational combination with BD’s Biosciences & Diagnostic Solutions business
